Evidence map›Paper›PMID 32092871›Full record

ArticleInternational journal of molecular sciences2020

OmixLitMiner: A Bioinformatics Tool for Prioritizing Biological Leads from 'Omics Data Using Literature Retrieval and Data Mining.

Pascal Steffen, Jemma Wu, Shubhang Hariharan, Hannah Voss, Vijay Raghunath, Mark P Molloy, Hartmut Schlüter

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Pascal SteffenBowel Cancer and Biomarker Research, Kolling Institute, The University of Sydney, Sydney 2065, Australia.ORCID 0000-0003-3883-699X
Jemma WuDepartment of Molecular Sciences, Macquarie University, Sydney 2109, Australia.
Shubhang HariharanBowel Cancer and Biomarker Research, Kolling Institute, The University of Sydney, Sydney 2065, Australia.
Hannah VossMass Spectrometric Proteomics Group, Department of Clinical Chemistry and Laboratory Medicine, University Medical Center Hamburg-Eppendorf (UKE), Hamburg 20246, Germany.
Vijay RaghunathSydney Informatics Hub, The University of Sydney, Sydney 2008, Australia.
Mark P MolloyBowel Cancer and Biomarker Research, Kolling Institute, The University of Sydney, Sydney 2065, Australia.
Hartmut SchlüterMass Spectrometric Proteomics Group, Department of Clinical Chemistry and Laboratory Medicine, University Medical Center Hamburg-Eppendorf (UKE), Hamburg 20246, Germany.ORCID 0000-0002-9358-7036

Funding

Deutscher Akademischer Austausch Dienst (DAAD), Germany 57172988
6 · The paper itself

Abstract

Proteomics and genomics discovery experiments generate increasingly large result tables, necessitating more researcher time to convert the biological data into new knowledge. Literature review is an important step in this process and can be tedious for large scale experiments. An informed and strategic decision about which biomolecule targets should be pursued for follow-up experiments thus remains a considerable challenge. To streamline and formalise this process of literature retrieval and analysis of discovery based 'omics data and as a decision-facilitating support tool for follow-up experiments we present OmixLitMiner, a package written in the computational language R. The tool automates the retrieval of literature from PubMed based on UniProt protein identifiers, gene names and their synonyms, combined with user defined contextual keyword search (i.e., gene ontology based). The search strategy is programmed to allow either strict or more lenient literature retrieval and the outputs are assigned to three categories describing how well characterized a regulated gene or protein is. The category helps to meet a decision, regarding which gene/protein follow-up experiments may be performed for gaining new knowledge and to exclude following already known biomarkers. We demonstrate the tool's usefulness in this retrospective study assessing three cancer proteomics and one cancer genomics publication. Using the tool, we were able to corroborate most of the decisions in these papers as well as detect additional biomolecule leads that may be valuable for future research.

Indexed as

SoftwareAlgorithmsComputational BiologyDatabases, FactualData MiningGene OntologyGenomicsHumansMass SpectrometryNeoplasmsProteomeProteomicsPublicationsPubMedRetrospective StudiesProteomebioinformaticsdata mininggenomicsliterature retrievalmass spectrometryproteomics

Identifiers

PMID32092871
PMCPMC7073124

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.